OU College of Medicine Names T.R. Lewis as Associate Dean for Student Affairs
The University of Oklahoma College of Medicine has announced the appointment of T.R. Lewis, M.D., as associate dean for student affairs, effective Jan. 25, 2026, pending approval by the OU Board of Regents.
OU College of Medicine Announces New Associate Dean for Veterans Affairs
The University of Oklahoma College of Medicine has named Kelly Stratton, M.D., FACS, as associate dean for veterans affairs, pending approval by the OU Board of Regents.
OU Helps Lead Clinical Trial Seeking Improved Survival for Head and Neck Cancer Patients
A newly approved National Cancer Institute-funded clinical trial aims to improve survival for head and neck cancer patients whose disease returns after radiation therapy – a setback that affects up to 40% of patients and is often associated with poor outcomes.
Naqash Honored by American Society for Clinical Investigation
Abdul Rafeh Naqash, M.D., associate professor of medicine at the University of Oklahoma College of Medicine and senior associate director of AI and Data Science at OU Health Stephenson Cancer Center, has been awarded the 2026 Young Physician-Scientist Award from the American Society for Clinical...
Maternal Microbiome Compound May Hold Key to Preventing Liver Disease
Children born to mothers who consume a high-fat, high-sugar diet during pregnancy and breastfeeding face a higher risk of developing fatty liver disease later in life. New research from the University of Oklahoma suggests that risk may be reduced: A study found that supplementing pregnant and...
Clinical Trial Shows Survival Benefit With Proton Therapy
Results of a Phase III clinical trial published recently in The Lancet show that oropharyngeal cancer patients receiving proton therapy kept their cancer under control just as well as patients receiving traditional radiation therapy, or photon therapy. Importantly, patients treated with proton...
University of Oklahoma, West Virginia University Researchers Earn NIH Grant to Study ‘Concept’ Flavored Cigarillos
Cigarillos, a small type of cigar, have dramatically risen in popularity, particularly those that come in flavors, such as cherry or chocolate. Some state and local laws have banned all flavored cigars, and the Food and Drug Administration has announced its intention for a federal ban. In...
OU Receives $25 Million Grant from TSET to Expand Statewide Cancer Care
The Oklahoma Tobacco Settlement Endowment Trust (TSET) has awarded the University of Oklahoma a $25 million grant to help construct a new OU Health Stephenson Cancer Center facility in Tulsa, a project that will house the newly named TSET Clinical Research Center and significantly expand access...
OU Study Links Genetic Variants to Risk of Blinding Eye Disease in Premature Infants
A new study from the University of Oklahoma suggests that small genetic differences in two proteins – previously known for their role in premature infants’ lungs – may also influence how their eyes develop, potentially affecting the risk of retinopathy of prematurity (ROP).
GLP-1 Drugs Show Potential Anti-Cancer Effects, Review Article Finds
The success of GLP-1 medications for treating Type 2 diabetes and obesity naturally leads to a related question: Do GLP-1 drugs affect cancer risk, which is often associated with obesity and Type 2 diabetes?
FDA Grants Fast Track Designation to Drug Combo for Colorectal Cancer
The U.S. Food and Drug Administration has granted Fast Track Designation to a new drug combination for metastatic colorectal cancer, following encouraging results from a clinical trial led in part by the University of Oklahoma Health Stephenson Cancer Center. The treatment offers potential hope...
Naqash Named Fellow of American Society of Clinical Oncology
Abdul Rafeh Naqash, M.D., associate professor at the University of Oklahoma College of Medicine and an oncologist at OU Health Stephenson Cancer Center, has been named a fellow of the American Society of Clinical Oncology (FASCO).
Gala Raises $4.7 Million for OU Health Harold Hamm Diabetes Center
OKLAHOMA CITY – More than 800 people attended the 2025 Connect+Cure Gala on Wednesday night, raising $4.7 million to support research and programs at the University of Oklahoma Health Harold Hamm Diabetes Center.
OU Cancer Researcher Elected Foreign Fellow to Indian National Science Academy
Citing a background of innovative cancer research, the Indian National Science Academy (INSA) has elected OU’s Priyabrata Mukherjee, Ph.D., as a foreign fellow. His fellowship will begin Jan. 1, 2026. Mukherjee is a tenured professor of pathology at the OU College of Medicine whose...
OU Health Recruits Top Pediatric Leader to Advance Care, Research and Training
Michael Steiner, M.D., M.P.H., a nationally recognized physician leader in pediatric medicine and health services research, has been named chair of the Department of Pediatrics at the University of Oklahoma College of Medicine and clinical service chief of pediatrics at OU Health. In these dual...
OU College of Medicine Researcher Named President-Elect of International Association of Pancreatology
Min Li, Ph.D., George Lynn Cross Research Professor of Medicine, Surgery and Cell Biology at the University of Oklahoma College of Medicine, has been named president-elect of the International Association of Pancreatology (IAP).
OU Undergraduate Research Program to Expand with $1 Million NIH Grant
With a new grant from the National Institutes of Health, the University of Oklahoma Health Stephenson Cancer Center is growing its mission of building the next generation of health professionals.
OU Health Campus Celebrates Doubling of Phase 1 Clinical Trials, New Laboratory Space
On Tuesday, OU Health Stephenson Cancer Center celebrated the expansion of its Oklahoma Phase 1 Clinical Trials Center, which will soon double the number of patients receiving early-stage cancer drugs. In addition, nearly 20,000 square feet of laboratory space has been added on the OU Health...
Study Illuminates Contributing Factors to Blood Vessel Leakage
A new study from the University of Oklahoma reveals how a little-understood protein, CD82, contributes to blood vessel leakage, a process that initiates inflammation but becomes dangerous when it occurs during severe inflammatory diseases such as sepsis, acute respiratory distress syndrome and...
OU College of Medicine Honors Leaders in Health Care at Evening of Excellence
Nearly 600 alumni, faculty, students and friends gathered on Sept. 4 at the Omni Oklahoma City Downtown Hotel for the University of Oklahoma College of Medicine’s Evening of Excellence. The annual gala was especially meaningful this year as the college celebrated its 125th anniversary and...